Evidence map›Paper›PMID 33859287›Full record

ArticleScientific reports2021

Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity.

Justin E LaVigne, Ryan Hecksel, Attila Keresztes, John M Streicher

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
13.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 113 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Comparative Anti-Obesity Potential of Cannabigerol-DominantInternational journal of molecular sciences · 2026
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Structural basis of the inhibition of TRPV1 by analgesic sesquiterpenes.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Justin E LaVigneDepartment of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA.ORCID 0000-0001-7653-0823
Ryan HeckselDepartment of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA.ORCID 0000-0003-4189-6950
Attila KeresztesDepartment of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA.ORCID 0000-0001-5028-8688
John M StreicherDepartment of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA. jstreicher@arizona.edu.ORCID 0000-0002-4173-7362
University of Arizona · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Limited evidence has suggested that terpenes found in Cannabis sativa are analgesic, and could produce an "entourage effect" whereby they modulate cannabinoids to result in improved outcomes. However this hypothesis is controversial, with limited evidence. We thus investigated Cannabis sativa terpenes alone and with the cannabinoid agonist WIN55,212 using in vitro and in vivo approaches. We found that the terpenes α-humulene, geraniol, linalool, and β-pinene produced cannabinoid tetrad behaviors in mice, suggesting cannabimimetic activity. Some behaviors could be blocked by cannabinoid or adenosine receptor antagonists, suggesting a mixed mechanism of action. These behavioral effects were selectively additive with WIN55,212, suggesting terpenes can boost cannabinoid activity. In vitro experiments showed that all terpenes activated the CB1R, while some activated other targets. Our findings suggest that these Cannabis terpenes are multifunctional cannabimimetic ligands that provide conceptual support for the entourage effect hypothesis and could be used to enhance the therapeutic properties of cannabinoids.

Indexed as

CannabisAnimalsBehavior, AnimalBenzoxazinesCannabinoid Receptor AgonistsCannabinoidsCatalepsyCHO CellsCricetulusDrug SynergismFemaleLocomotionMaleMiceMice, Inbred ICRMorpholines(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanoneBenzoxazinesCannabinoid Receptor AgonistsCannabinoidsMorpholinesNaphthalenesReceptor, Cannabinoid, CB1Terpenes

Identifiers

PMID33859287
PMCPMC8050080
OpenAlexW3152710445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.